← Leaderboards
Seymour None Grufferman
University Of Pittsburgh At Pittsburgh
$2,334,860
Attributed
$2,334,860
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$2,334,860 · 1
By mechanism
R01$2,334,860 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Pittsburgh At Pittsburgh
Same institution · by research overlap
- Roy A Mariuzza$20,943,458
- Charles R Rinaldo$100,535,685
- Fadi G. Lakkis$19,632,585
- Ronald C Montelaro$16,007,779
- Kathy Shair$2,253,203
Others in their field
Top investigators on “Adolescence (12-20)”
- Kathryn Hirst · Caritas St. Elizabeth'S Medical Center$38,407,013
- Lloyd D Johnston · University Of Michigan At Ann Arbor$26,271,656
- Stephen A Spector · University Of California, San Diego$21,510,628
- Richard L Spoth · Iowa State University$19,460,648
- Craig M Wilson · University Of Alabama At Birmingham$18,374,977
- Gregory H Reaman · National Childhood Cancer Foundation$17,052,970
Research focus
Adolescence (12-20)Antiviral AntibodyCancer RiskChild (0-11)Clinical ResearchDisease /Disorder EtiologyEnvironment Related Neoplasm /CancerEpstein Barr VirusGene Environment InteractionGenetic MarkersGenetic SusceptibilityGenotypeHispanic AmericansHistocompatibility AntigensHistocompatibility GeneHistocompatibility TypingHodgkin'S DiseaseHuman SubjectLinkage MappingNeoplasm /Cancer EpidemiologyNeoplasm /Cancer GeneticsOccupationsPediatric Neoplasm /CancerSerology /Serodiagnosis
Grant awards (5)
CASE-CONTROL STUDY OF HODGKIN'S DISEASE IN CHILDREN$257,529
R01 · FY2003 · CA
CASE-CONTROL STUDY OF HODGKIN'S DISEASE IN CHILDREN$157,431
R01 · FY2003 · CA
CASE-CONTROL STUDY OF HODGKIN'S DISEASE IN CHILDREN$493,949
R01 · FY2002 · CA
CASE-CONTROL STUDY OF HODGKIN'S DISEASE IN CHILDREN$617,535
R01 · FY2001 · CA
CASE-CONTROL STUDY OF HODGKIN'S DISEASE IN CHILDREN$808,416
R01 · FY2000 · CA